Spectral Diagnostics (EDTXF) Stock Price, News & Analysis

Company Overview

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.61 to $0.62
• 50-Day Range: $0.49 to $0.65
• 52-Week Range: $0.32 to $0.65
• Volume: 9,014 shs
• Average Volume: 11,561 shs
• Market Capitalization: $174.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EDTXF Stock Analysis - Frequently Asked Questions

How have EDTXF shares performed this year?

Spectral Diagnostics' stock was trading at $0.3474 at the beginning of 2025. Since then, EDTXF stock has increased by 75.7% and is now trading at $0.6105.
View the best growth stocks for 2025 here.

How were Spectral Diagnostics' earnings last quarter?

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) announced its earnings results on Friday, May, 9th. The company reported ($0.03) EPS for the quarter. The firm had revenue of $0.40 million for the quarter.

How do I buy shares of Spectral Diagnostics?

Shares of EDTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/09/2025
• Today: 6/19/2025
• Next Earnings (Estimated): 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EDTXF
• Previous Symbol: OTCMKTS:DIAGF
• CIK: N/A
• Web: www.spectraldx.com
• Phone: (416) 626-3233
• Fax: 416-626-7383
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$11.24 million
• Net Margins: -1,078.10%
• Pretax Margin: -1,077.59%
• Return on Equity: N/A
• Return on Assets: -336.97%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.09
• Quick Ratio: 0.08

Sales & Book Value

• Annual Sales: $1.67 million
• Price / Sales: 104.23
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.07) per share
• Price / Book: -8.72

Miscellaneous

• Outstanding Shares: 285,120,000
• Free Float: 280,840,000
• Market Cap: $174.07 million
• Optionable: Not Optionable
• Beta: 0.23